pharmaceutical company

Obesity Surgery May Become Option for Many More

NYT > Business  Wed, 12/01/2010 - 22:00

Food and Drug Administration advisers will consider a request by a pharmaceutical company to lower how obese someone must be to qualify for surgery using its device.


 

GSK receives EU approval for prostate drug

Newsvine - business  Wed, 03/31/2010 - 05:07

Pharmaceutical company GlaxoSmithKline PLC said Wednesday it has received European approval for Duodart, a two-in-one drug for the treatment of the symptoms of an enlarged prostate.


 

Drugmaker Eli Lilly reports 4Q profit, sales jump

Newsvine - business  Thu, 01/28/2010 - 05:51

Pharmaceutical company Eli Lilly and Co. says it turned a fourth-quarter profit after recording a loss in 2008 following the buyout of cancer drug maker ImClone Systems Inc.


 

Johnson & Johnson Plans Cuts and a $1.3 Billion Charge

Topix - Business News  Wed, 11/04/2009 - 14:15

Johnson & Johnson , the pharmaceutical company, said Tuesday it would trim layers of management, cut jobs and make other restructuring moves to save up to $900 million next year.


 

Bayer names Dekkers as next CEO

Newsvine - business  Tue, 09/15/2009 - 04:58

German chemical and pharmaceutical company Bayer AG announced Tuesday that it has tapped Marijn Dekkers to take over as its chief executive in October 2010.


 

Mylan names Heather Bresch president

Newsvine - business  Wed, 07/29/2009 - 04:59

Pharmaceutical company Mylan Inc. says it promoted chief operating officer Heather Bresch to the post of president.


 

Court to consider whether to allow Vioxx lawsuits

Newsvine - business  Tue, 05/26/2009 - 08:09

The Supreme Court will decide whether shareholders can sue pharmaceutical company Merck & Co. because of the failure of its former blockbuster painkiller Vioxx.


 

Unusual 11 Mid-Day Movers 5/18: KONA, IDMI, GRO, REDF Higher; SP...

StreetInsider.com News Articles  Mon, 05/18/2009 - 10:53

Kona Grill Inc. (Nasdaq: KONA) 69.1% HIGHER; In an amended 13D filing on Kona, 9.8% holder Mill Road Capital disclosed a non-binding offer to acquire all of the Company’s shares for cash in a transaction valuing Kona's total enterprise value at $27.9 million or $4.60 per share.

IDM Pharma, Inc. (Nasdaq: IDMI) 53.5% HIGHER; Takeda Pharmaceutical Company Limited agreed to acquire IDM Pharma for US$2.64 per share in cash.

Shares of IDMI closed at $1.70 per share on Friday, representing a deal premium of 55%.